Log in

Applied DNA Sciences Stock Forecast, Price & News

-0.48 (-5.83 %)
(As of 09/18/2020 10:04 PM ET)
Today's Range
Now: $7.76
50-Day Range
MA: $8.82
52-Week Range
Now: $7.76
Volume248,700 shs
Average Volume1.32 million shs
Market Capitalization$39.91 million
P/E RatioN/A
Dividend YieldN/A
Applied DNA Sciences, Inc. develops and markets plat based or other DNA technology solution in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that are ingredients used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNature T molecular tags, which are tagging and authentication systems for use in brand protection efforts and raw material source compliance programs; and fiberTyping, a test of native cotton fiber DNA. It also provides DNAnet, Smart DNA, and Backtrac that are molecular tags to link evidence and offenders to specific crime scenes; Beacon locked optical markers, which create a protected covert screening tool that can be adapted to packaging, security labels, and high-value assets through inks, varnishes, and coatings; and SigNify IF portable DNA readers that provides real-time authentication of molecular tags. In addition, the company offers Applied DNA Sciences Portal, a software platform that enables customers to manage the security of company-marked goods from point of marking to point of authentication or validation to end of life; and DNA Transfer Systems and Cannabis Tracking System, which offer remote Internet access for real-time monitoring. Further, it provides CertainT Supply Chain Platform that provides proof of product claims for materials, items, or products; and Triathlon PCR systems that allow for the large-scale production of specific DNA sequences. Additionally, the company offers contract research services for the nucleic acid-based medical and biologic markets; and various RNA based drug and biologic customers for preclinical studies. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
Read More
Applied DNA Sciences logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.97 out of 5 stars

Industry, Sector and Symbol

Industry Miscellaneous business services
Current SymbolNASDAQ:APDN



Sales & Book Value

Annual Sales$5.39 million
Book Value($0.71) per share


Net Income$-8,620,000.00
Net Margins-304.46%


Market Cap$39.91 million
Next Earnings Date12/10/2020 (Estimated)
-0.48 (-5.83 %)
(As of 09/18/2020 10:04 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive APDN News and Ratings via Email

Sign-up to receive the latest news and ratings for APDN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Applied DNA Sciences (NASDAQ:APDN) Frequently Asked Questions

How has Applied DNA Sciences' stock been impacted by Coronavirus?

Applied DNA Sciences' stock was trading at $4.10 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, APDN shares have increased by 89.3% and is now trading at $7.76.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Applied DNA Sciences?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Applied DNA Sciences in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Applied DNA Sciences

When is Applied DNA Sciences' next earnings date?

Applied DNA Sciences is scheduled to release its next quarterly earnings announcement on Thursday, December 10th 2020.
View our earnings forecast for Applied DNA Sciences

How were Applied DNA Sciences' earnings last quarter?

Applied DNA Sciences Inc (NASDAQ:APDN) posted its quarterly earnings data on Thursday, August, 6th. The technology company reported ($0.72) EPS for the quarter, missing analysts' consensus estimates of ($0.62) by $0.10. The technology company had revenue of $0.43 million for the quarter, compared to analysts' expectations of $0.50 million. Applied DNA Sciences had a negative net margin of 304.46% and a negative return on equity of 180.24%.
View Applied DNA Sciences' earnings history

What price target have analysts set for APDN?

2 brokers have issued 1-year price targets for Applied DNA Sciences' stock. Their forecasts range from $21.00 to $22.00. On average, they anticipate Applied DNA Sciences' stock price to reach $21.50 in the next year. This suggests a possible upside of 177.1% from the stock's current price.
View analysts' price targets for Applied DNA Sciences

Are investors shorting Applied DNA Sciences?

Applied DNA Sciences saw a increase in short interest in the month of August. As of August 14th, there was short interest totaling 585,300 shares, an increase of 49.3% from the July 30th total of 392,100 shares. Based on an average daily trading volume, of 1,280,000 shares, the short-interest ratio is currently 0.5 days. Currently, 13.4% of the shares of the company are sold short.
View Applied DNA Sciences' Short Interest

Who are some of Applied DNA Sciences' key competitors?

What other stocks do shareholders of Applied DNA Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Applied DNA Sciences investors own include Inovio Pharmaceuticals (INO), Gilead Sciences (GILD), VBI Vaccines (VBIV), Advanced Micro Devices (AMD), Novavax (NVAX), Vaxart (VXRT), Pfizer (PFE), Ekso Bionics (EKSO), Johnson & Johnson (JNJ) and Dynavax Technologies (DVAX).

Who are Applied DNA Sciences' key executives?

Applied DNA Sciences' management team includes the following people:
  • Dr. James A. Hayward Ph.D., Sc.D., Pres, CEO & Chairman (Age 65)
  • Ms. Beth M. Jantzen CPA, CPA, Chief Financial Officer (Age 43)
  • Ms. Judith Murrah, Chief Information Officer & Sec. (Age 61)
  • Mr. Clay Shorrock Esq., Gen. Counsel
  • Mr. Tony Benson, Managing Director of EMEA

What is Applied DNA Sciences' stock symbol?

Applied DNA Sciences trades on the NASDAQ under the ticker symbol "APDN."

Who are Applied DNA Sciences' major shareholders?

Applied DNA Sciences' stock is owned by a number of institutional and retail investors. Top institutional investors include Virtu Financial LLC (0.42%), UBS Group AG (0.26%), Creative Planning (0.22%) and Rockefeller Capital Management L.P. (0.10%).
View institutional ownership trends for Applied DNA Sciences

Which major investors are buying Applied DNA Sciences stock?

APDN stock was purchased by a variety of institutional investors in the last quarter, including Virtu Financial LLC, UBS Group AG, Creative Planning, and Rockefeller Capital Management L.P..
View insider buying and selling activity for Applied DNA Sciences

How do I buy shares of Applied DNA Sciences?

Shares of APDN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Applied DNA Sciences' stock price today?

One share of APDN stock can currently be purchased for approximately $7.76.

How big of a company is Applied DNA Sciences?

Applied DNA Sciences has a market capitalization of $39.91 million and generates $5.39 million in revenue each year. The technology company earns $-8,620,000.00 in net income (profit) each year or ($10.46) on an earnings per share basis. Applied DNA Sciences employs 59 workers across the globe.

What is Applied DNA Sciences' official website?

The official website for Applied DNA Sciences is www.adnas.com.

How can I contact Applied DNA Sciences?

Applied DNA Sciences' mailing address is 50 HEALTH SCIENCES DRIVE, STONY BROOK NY, 11790. The technology company can be reached via phone at 631-840-8800 or via email at [email protected]

This page was last updated on 9/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.